HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Eleonora Rosati Selected Research
Eleonora Rosati Research Topics
Disease
8
Epilepsy (Aura)
05/2024 - 10/2014
5
Partial Epilepsies (Epilepsy, Partial)
11/2023 - 01/2021
4
Seizures (Absence Seizure)
12/2022 - 04/2009
2
Generalized Epilepsy
10/2014 - 04/2009
1
Idiopathic Generalized Epilepsy
05/2024
1
Stroke (Strokes)
04/2022
1
Encephalitis (Encephalitis, Rasmussen)
01/2022
1
Glioma (Gliomas)
01/2022
1
Status Epilepticus (Complex Partial Status Epilepticus)
03/2021
1
Cognitive Dysfunction
01/2021
1
Febrile Seizures (Febrile Seizure)
01/2021
1
Channelopathies
04/2020
1
Melanoma (Melanoma, Malignant)
10/2017
1
Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
08/2008
1
Multiple Sclerosis
08/2002
Drug/Important Bio-Agent (IBA)
9
brivaracetam
IBA
11/2023 - 01/2021
4
Anticonvulsants (Antiepileptic Drugs)
IBA
01/2021 - 10/2014
2
Levetiracetam (Keppra)
FDA Link
Generic
05/2024 - 01/2021
2
Antibodies
IBA
01/2022 - 08/2008
2
Proteins (Proteins, Gene)
FDA Link
01/2022 - 01/2022
1
Immunoglobulin E (IgE)
IBA
05/2024
1
Lamotrigine (Lamictal)
FDA Link
Generic
05/2024
1
Valproic Acid (Depakote)
FDA Link
Generic
05/2024
1
Monoclonal Antibodies
IBA
01/2022
1
Leucine (L-Leucine)
FDA Link
01/2022
1
perampanel
IBA
01/2021
1
Ion Channels (Ion Channel)
IBA
04/2020
1
2-chloro-5-nitrobenzanilide
IBA
10/2017
1
Melanocyte-Stimulating Hormones (MSH)
IBA
10/2017
1
Hormones (Hormone)
IBA
10/2017
1
Elements
IBA
10/2017
1
Transcription Factors (Transcription Factor)
IBA
10/2017
1
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
10/2017
1
Antidepressive Agents (Antidepressants)
IBA
04/2009
1
Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)
IBA
04/2009
1
Norepinephrine (Noradrenaline)
FDA Link
Generic
04/2009
1
Serotonin and Noradrenaline Reuptake Inhibitors
IBA
04/2009
1
Serotonin (5 Hydroxytryptamine)
IBA
04/2009
1
Glutamate Decarboxylase (Decarboxylase, Glutamate)
IBA
08/2008
1
Leukocyte Common Antigens (CD45 Antigen)
IBA
08/2002
Therapy/Procedure
2
Therapeutics
01/2022 - 01/2021
1
Immunotherapy
01/2022
1
Off-Label Use
10/2014